Zobrazeno 1 - 10
of 710
pro vyhledávání: ''
Autor:
Annemiek K. E. van Hemert, Josefien P. van Olmen, Liesbeth J. Boersma, John H. Maduro, Nicola S. Russell, Jolien Tol, Ellen G. Engelhardt, Emiel J. Th. Rutgers, Marie-Jeanne T. F. D. Vrancken Peeters, Frederieke H. van Duijnhoven
Publikováno v:
Breast Cancer Research and Treatment, 199(1), 81-89. SPRINGER
Breast Cancer Research and Treatment, 199, 81-89. Springer, Cham
Breast Cancer Research and Treatment, 199, 81-89. Springer, Cham
Purpose: Neoadjuvant systemic therapy (NST) is increasingly used in breast cancer patients and depending on subtype, 10–89% of patients will attain pathologic complete response (pCR). In patients with pCR, risk of local recurrence (LR) after breast
Publikováno v:
Familial Cancer 22 (2023) 2
Familial Cancer. Springer Netherlands
Familial Cancer, 22(2), 155-166. Springer, Cham
Familial Cancer, 22, 155-166
Hoedjes, M, Vrieling, A, de Brauwer, L, Visser, A, Gómez García, E, Hoogerbrugge, N & Kampman, E 2022, ' Determinants of adherence to recommendations on physical activity, red and processed meat intake, and body weight among lynch syndrome patients ', Familial Cancer . https://doi.org/10.1007/s10689-022-00315-y
Familial Cancer, 22(2), 155-166
Familial Cancer, 22, 2, pp. 155-166
Familial Cancer, 22(2), 155-166. Springer
Familial Cancer. Springer Netherlands
Familial Cancer, 22(2), 155-166. Springer, Cham
Familial Cancer, 22, 155-166
Hoedjes, M, Vrieling, A, de Brauwer, L, Visser, A, Gómez García, E, Hoogerbrugge, N & Kampman, E 2022, ' Determinants of adherence to recommendations on physical activity, red and processed meat intake, and body weight among lynch syndrome patients ', Familial Cancer . https://doi.org/10.1007/s10689-022-00315-y
Familial Cancer, 22(2), 155-166
Familial Cancer, 22, 2, pp. 155-166
Familial Cancer, 22(2), 155-166. Springer
Contains fulltext : 291303.pdf (Publisher’s version ) (Open Access) This study aimed to identify determinants of adherence to lifestyle and body weight recommendations for cancer prevention among Lynch Syndrome (LS) patients. Cross-sectional baseli
Autor:
Julia Hoffmann, Sabine Hanß, Monika Kraus, Jens Schaller, Christian Schäfer, Dana Stahl, Stefan D. Anker, Gabriele Anton, Thomas Bahls, Stefan Blankenberg, Arne Blumentritt, Leif-Hendrik Boldt, Steffen Cordes, Steffen Desch, Wolfram Doehner, Marcus Dörr, Frank Edelmann, Ingo Eitel, Matthias Endres, Stefan Engelhardt, Jeanette Erdmann, Katharina Eulenburg, Volkmar Falk, Stephan B. Felix, Derk Frank, Thomas Franke, Norbert Frey, Tim Friede, Lars Geidel, Lisa Germans, Ulrich Grabmaier, Martin Halle, Jörg Hausleiter, Vera Jakobi, Ahmad-Fawad Jebran, Alexander Jobs, Stefan Kääb, Mahir Karakas, Hugo A. Katus, Alexandra Klatt, Christoph Knosalla, Joachim Krebser, Ulf Landmesser, Mahsa Lee, Kristin Lehnert, Stephanie Lesser, Katrin Leyh, Roberto Lorbeer, Stephanie Mach-Kolb, Benjamin Meder, Eike Nagel, Christian H. Nolte, Abdul S. Parwani, Astrid Petersmann, Miriam Puls, Henriette Rau, Maximilian Reiser, Otto Rienhoff, Tabea Scharfe, Mario Schattschneider, Heiko Scheel, Renate B. Schnabel, Andreas Schuster, Boris Schmitt, Tim Seidler, Moritz Seiffert, Barbara-Elisabeth Stähli, Adriane Stas, Thomas J. Stocker, Lukas von Stülpnagel, Holger Thiele, Rolf Wachter, Reza Wakili, Tanja Weis, Kerstin Weitmann, Heinz-Erich Wichmann, Philipp Wild, Tanja Zeller, Wolfgang Hoffmann, Elisabeth Maria Zeisberg, Wolfram-Hubertus Zimmermann, Dagmar Krefting, Titus Kühne, Annette Peters, Gerd Hasenfuß, Steffen Massberg, Thomas Sommer, Stefanie Dimmeler, Thomas Eschenhagen, Matthias Nauck
Publikováno v:
Clinical research in cardiology 112(7), 923-941 (2023). doi:10.1007/s00392-023-02177-5
The German Centre for Cardiovascular Research (DZHK) is one of the German Centres for Health Research and aims to conduct early and guideline-relevant studies to develop new therapies and diagnostics that impact the lives of people with cardiovascula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::986db796b67af3fabbebd951d15d4837
http://edoc.mdc-berlin.de/23192/1/23192oa.pdf
http://edoc.mdc-berlin.de/23192/1/23192oa.pdf
Autor:
Sars, Carl, Sackey, Helena, Frisell, Jan, Dickman, Paul W, Karlsson, Fredrik, Kindts, Isabelle, Marta, Gustavo Nader, Freitas-Junior, Ruffo, Tvedskov, Tove Filtenborg, Kassem, Loay, Ali, Ahmed S, Ihalainen, Hanna, Neron, Mathias, Kontos, Michalis, Kaidar-Person, Orit, Meattini, Icro, Francken, Anne Brecht, van Duijnhoven, Frederieke, Moberg, Ingvild Ona, Marinko, Tanja, Kollár, Attila, Ahmed, Mahbubl, Remoundos, Dennis, Banks, Jenny, Jagsi, Reshma, Dossett, Lesly A, Lindqvist, Ebba K
Publikováno v:
Sars, Carl; Sackey, Helena; Frisell, Jan; Dickman, Paul W; Karlsson, Fredrik; Kindts, Isabelle; Marta, Gustavo Nader; Freitas-Junior, Ruffo; Tvedskov, Tove Filtenborg; Kassem, Loay; Ali, Ahmed S; Ihalainen, Hanna; Neron, Mathias; Kontos, Michalis; Kaidar-Person, Orit; Meattini, Icro; Francken, Anne Brecht; van Duijnhoven, Frederieke; Moberg, Ingvild Ona; Marinko, Tanja; ... (2023). Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists. Breast cancer research and treatment, 199(2), pp. 293-304. Springer 10.1007/s10549-023-06896-1
Purpose Phyllodes tumors of the breast are rare fibroepithelial lesions that are classified as benign, borderline or malignant. There is little consensus on best practice for the work-up, management, and follow-up of patients with phyllodes tumors of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0916ddfc2ee70c618897b252551e780b
https://boris.unibe.ch/179604/1/s10549-023-06896-1.pdf
https://boris.unibe.ch/179604/1/s10549-023-06896-1.pdf
Autor:
Mahmoud Mohammadi, Thekla M. Jansen-Werkhoven, Nikki S. Ijzerman, Dide den Hollander, Roos F. Bleckman, Astrid W. Oosten, Ingrid M. E. Desar, An K. L. Reyners, Neeltje Steeghs, Hans Gelderblom
Publikováno v:
Targeted Oncology, 17, 6, pp. 627-634
Targeted oncology, 17(6), 627-634. SPRINGER
Targeted Oncology, 17, 627-634
Targeted Oncology, 17(6), 627-634. Springer Paris
Targeted Oncology, 17(6), 627-634. SPRINGER
Targeted oncology, 17(6), 627-634. SPRINGER
Targeted Oncology, 17, 627-634
Targeted Oncology, 17(6), 627-634. Springer Paris
Targeted Oncology, 17(6), 627-634. SPRINGER
Contains fulltext : 287667.pdf (Publisher’s version ) (Open Access) BACKGROUND: The prognosis of patients with advanced gastrointestinal stromal tumor (GIST) has improved greatly after the introduction of imatinib. However, primary or secondary res
Autor:
Sebastian Martin, David Viertl, Anna Janz, Stefan Habringer, Ulrich Keller, Margret Schottelius
Background CXCR4-targeted radioligand therapy (RLT) with [177Lu]Lu/[90Y]Y-PentixaTher has recently evolved as a promising therapeutic option for patients with advanced hematological cancers. Given their advanced disease stage, most patients scheduled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47f50a96a14ccf0d2dcd1d10addfd2d8
http://edoc.mdc-berlin.de/23353/1/23353oa.pdf
http://edoc.mdc-berlin.de/23353/1/23353oa.pdf
Autor:
Alessio Fiascarelli, Giuseppe Merlino, Stefania Capano, Simone Talucci, Diego Bisignano, Alessandro Bressan, Daniela Bellarosa, Corrado Carrisi, Alessandro Paoli, Mario Bigioni, Patrizia Tunici, Clelia Irrissuto, Massimiliano Salerno, Joaquin Arribas, Elisa de Stanchina, Maurizio Scaltriti, Monica Binaschi
Publikováno v:
Scientia
Purpose Dysregulation of the PI3K pathway is one of the most common events in breast cancer. Here we investigate the activity of the PI3K inhibitor MEN1611 at both molecular and phenotypic levels by dissecting and comparing its profile and efficacy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106976cb77db0f365733f8e2231bb9ed
https://hdl.handle.net/11351/9983
https://hdl.handle.net/11351/9983
Autor:
Rijken, Anouk, van de Vlasakker, Vincent C.J., Simkens, Geert A., Rovers, Koen P., van Erning, Felice N., Koopman, Miriam, Verhoef, Cornelis, de Wilt, Johannes H.W., de Hingh, Ignace H.J.T.
Publikováno v:
Clinical and Experimental Metastasis. Springer Netherlands
Rijken, A, van de Vlasakker, V C J, Simkens, G A, Rovers, K P, van Erning, F N, Koopman, M, Verhoef, C, de Wilt, J H W & de Hingh, I H J T 2023, ' Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study ', Clinical and Experimental Metastasis, vol. 40, no. 4 . https://doi.org/10.1007/s10585-023-10212-y
Rijken, A, van de Vlasakker, V C J, Simkens, G A, Rovers, K P, van Erning, F N, Koopman, M, Verhoef, C, de Wilt, J H W & de Hingh, I H J T 2023, ' Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study ', Clinical and Experimental Metastasis, vol. 40, no. 4 . https://doi.org/10.1007/s10585-023-10212-y
Limited data are available to guide the decision-making process for clinicians and their patients regarding palliative treatment options for patients with isolated synchronous colorectal cancer peritoneal metastases (CRC-PM). Therefore, the aim of th
Autor:
Fuellen, G., Walter, U., Henze, L., Böhmert, J., Palmer, D., Lee, S., Schmitt, C.A., Rudolf, H., Kowald, A.
The most important predictors for outcomes after ischemic stroke, that is, for health deterioration and death, are chronological age and stroke severity; gender, genetics and lifestyle/environmental factors also play a role. Of all these, only the la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::4fb28801b6fdd96547119b0b40472b2f
http://edoc.mdc-berlin.de/22010/1/22010oa.pdf
http://edoc.mdc-berlin.de/22010/1/22010oa.pdf
Autor:
Leonhardt, S., Jürgensen, C., Frohme, J., Grajecki, D., Adler, A., Sigal, M., Leonhardt, J., Voll, J.M., Kruse, J.M., Körner, R., Eckardt, K.U., Janssen, H.J., Gebhardt, V., Schmittner, M.D., Frey, C., Müller-Ide, H., Bauer, M., Thibeault, C., Kurth, F., Sander, L.E., Müller, T., Tacke, F.
BACKGROUND: Increasing evidence suggests that secondary sclerosing cholangitis (SSC), which can lead to cirrhosis or liver failure, may be a hepatobiliary long-term complication of COVID-19. The aim of this study was to estimate the frequency and out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::6beafa0a2f543b0d1acf3cef7db1e1a6
http://edoc.mdc-berlin.de/23330/7/23330suppl.zip
http://edoc.mdc-berlin.de/23330/7/23330suppl.zip